120 related articles for article (PubMed ID: 22814462)
21. Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.
Jones RN; Biedenbach DJ; Erwin ME; Beach ML; Pfaller MA
J Clin Microbiol; 1999 Jun; 37(6):1999-2002. PubMed ID: 10325362
[TBL] [Abstract][Full Text] [Related]
22. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
23. Haemophilus influenzae, Pneumococci, group A streptococci and Staphylococcus aureus: sensitivity of outpatient strains to commonly prescribed antibiotics.
Forsgren A; Walder M
Scand J Infect Dis; 1982; 14(1):39-43. PubMed ID: 7041247
[TBL] [Abstract][Full Text] [Related]
24. Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
Bale MJ; Jones RN; Erwin ME; Koontz FP; Gerlach EH; Murray PR; Washington JA
J Clin Microbiol; 1992 Mar; 30(3):744-5. PubMed ID: 1313052
[TBL] [Abstract][Full Text] [Related]
25. Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitor.
Anderegg TR; Biedenbach DJ; Jones RN;
Int J Antimicrob Agents; 2003 Jul; 22(1):84-6. PubMed ID: 12842335
[No Abstract] [Full Text] [Related]
26. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
[TBL] [Abstract][Full Text] [Related]
27. Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories.
Hong SK; Choi SJ; Shin S; Lee W; Pinto N; Shin N; Lee K; Hong SG; Kim YA; Lee H; Kim H; Song W; Lee SH; Yong D; Lee K; Chong Y
Ann Lab Med; 2015 Nov; 35(6):635-8. PubMed ID: 26354353
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
[TBL] [Abstract][Full Text] [Related]
29. Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.
Min S; Ingraham K; Huang J; McCloskey L; Rilling S; Windau A; Pizzollo J; Butler D; Aubart K; Miller LA; Zalacain M; Holmes DJ; O'Dwyer K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4644-52. PubMed ID: 26014938
[TBL] [Abstract][Full Text] [Related]
30. Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.
Fuchs PC; Barry AL; Brown SD
J Clin Microbiol; 1997 Jan; 35(1):125-31. PubMed ID: 8968893
[TBL] [Abstract][Full Text] [Related]
31. Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium.
Doern GV; Gerlach EH; Jorgensen JH; Murray PR; Thornsberry C; Washington JA
Diagn Microbiol Infect Dis; 1991; 14(6):485-93. PubMed ID: 1802535
[TBL] [Abstract][Full Text] [Related]
32. Cyclopentanone ring-cleaved pleuromutilin derivatives.
Springer DM; Bunker A; Luh BY; Sorenson ME; Goodrich JT; Bronson JJ; DenBleyker K; Dougherty TJ; Fung-Tomc J
Eur J Med Chem; 2007 Jan; 42(1):109-13. PubMed ID: 17156897
[TBL] [Abstract][Full Text] [Related]
33. Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
Odland BA; Erwin ME; Jones RN
J Clin Microbiol; 2000 Jan; 38(1):453-5. PubMed ID: 10618141
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility testing of Streptococcus pneumoniae and Haemophilus influenzae --internal quality control as a quality tool on a national level.
Kärpänoja P; Nissinen A; Huovinen P; Sarkkinen H;
APMIS; 2013 Jun; 121(6):561-8. PubMed ID: 23163534
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the WIDER I system for antimicrobial susceptibility testing of clinical isolates of Haemophilus influenzae and Streptococcus pneumoniae.
Fernández-Cuenca F; Martínez-Martínez L; Pascual A; De Cueto M; Gutiérrez O; Nieto J; Perea EJ
Clin Microbiol Infect; 2003 May; 9(5):449-52. PubMed ID: 12848763
[TBL] [Abstract][Full Text] [Related]
36. Quality control parameters for cefditoren susceptibility tests.
Fuchs PC; Barry AL; Brown SD; Traczewski MM
Clin Microbiol Infect; 2001 Feb; 7(2):93-5. PubMed ID: 11298151
[No Abstract] [Full Text] [Related]
37. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
Jones RN; Barry AL
J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).
Sader HS; Paukner S; Ivezic-Schoenfeld Z; Biedenbach DJ; Schmitz FJ; Jones RN
J Antimicrob Chemother; 2012 May; 67(5):1170-5. PubMed ID: 22287234
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic Resistance Among Ocular Pathogens in the United States: Five-Year Results From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.
Asbell PA; Sanfilippo CM; Pillar CM; DeCory HH; Sahm DF; Morris TW
JAMA Ophthalmol; 2015 Dec; 133(12):1445-54. PubMed ID: 26502312
[TBL] [Abstract][Full Text] [Related]
40. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
